Final Segment #1:
 
CEO Interview
Glen Tullman, CEO
 
Friday, October 17, 2008
 

Jim's
rating on
this stock

STOCK
SYMBOL

Closing
price that
day

Full Company Name & Jim's Comments:

MDRX

5.33

Allscripts Healthcare Solutions Inc. (MDRX)

 

Jim:    On August 25th, we had the chairman and CEO of Allscripts Healthcare Solutions Inc. (MDRX), Glen Tullman, on Mad Money...

We like MDRX, because it takes costs out of the healthcare system by automating record keeping which is, by the way, something that Barack Obama has stressed is important to keep medical costs down...

Continued below...  

 

Market Results today:

Dow:  - 127

Nasdaq + 6

S&P 500:  - 6

 
 

Friday, October 17, 2008
(Cont'd from above)...

We said there'd be an event that would impact the stock... it would drop precipitously, because of this special event... and I want to show you what we're talking about... right here (as Jim points to the chart of October)... this particular decline... is why I'm bringing Mr. Tullman back on to explain why his stock just went down $5 bucks... and what it means to be ex-dividend, and what the new ownership structure means to you as a shareholder, because you've got to understand things like "ex-dividend" and what it does to a stock...

Here's Glen Tullman, chairman and CEO of MDRX.

Sir, welcome back...


Jim's comments AFTER the interview:   Alright, I want people to be familiar with what goes on, okay... when you have a big dividend, it is not a crisis. The stock did not get killed. He returned the money to you. He's got a better company than he did the last time he was on. If you believe that you're looking for a pure Barack Obama play, then
Allscripts Healthcare Solutions Inc. (MDRX) is for you.

 

Read Jim's next Segment here  
    

 

Previous Page

Next Page

See all of tonight's stocks mentioned, on Yahoo! Finance, here...

Search for Jim's past comments about a specific stock.  Use ticker symbol or company name in quotes (e.g., GOOG or "Google")

© 2005-2009  MadMoneyRecap.com    About Us    Important Disclaimers      

Feedback here.